HEADER TRANSCRIPTION 24-JUL-23 8K5R TITLE CDK9/CYCLIN T1 IN COMPLEX WITH KB-0742 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 9; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLIN-T1; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK9; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNT1; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KB-0742, CDK9/CYCLIN T1, CDK9, CYCLIN T1, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR M.ZHOU,H.LI,H.GAO,B.W.TROTTER,D.FREEMAN REVDAT 2 27-DEC-23 8K5R 1 JRNL REVDAT 1 06-DEC-23 8K5R 0 JRNL AUTH D.B.FREEMAN,T.D.HOPKINS,P.J.MIKOCHIK,J.P.VACCA,H.GAO, JRNL AUTH 2 A.NAYLOR-OLSEN,S.RUDRA,H.LI,M.S.POP,R.A.VILLAGOMEZ,C.LEE, JRNL AUTH 3 H.LI,M.ZHOU,D.C.SAFFRAN,N.RIOUX,T.R.HOOD,M.A.L.DAY, JRNL AUTH 4 M.R.MCKEOWN,C.Y.LIN,N.BISCHOFBERGER,B.W.TROTTER JRNL TITL DISCOVERY OF KB-0742, A POTENT, SELECTIVE, ORALLY JRNL TITL 2 BIOAVAILABLE SMALL MOLECULE INHIBITOR OF CDK9 FOR JRNL TITL 3 MYC-DEPENDENT CANCERS. JRNL REF J.MED.CHEM. V. 66 15629 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37967851 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01233 REMARK 2 REMARK 2 RESOLUTION. 3.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0352 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 85.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 10789 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.977 REMARK 3 FREE R VALUE TEST SET COUNT : 537 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 794 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3760 REMARK 3 BIN FREE R VALUE SET COUNT : 34 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4537 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 200.6 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.50800 REMARK 3 B22 (A**2) : -2.50800 REMARK 3 B33 (A**2) : 8.13500 REMARK 3 B12 (A**2) : -1.25400 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.625 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.551 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 42.140 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4661 ; 0.003 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 4330 ; 0.004 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6321 ; 0.856 ; 1.651 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10092 ; 0.300 ; 1.565 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 552 ; 6.612 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 32 ; 2.549 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 831 ;13.490 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 711 ; 0.039 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5181 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 905 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 970 ; 0.234 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 26 ; 0.231 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2288 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 120 ; 0.131 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2226 ; 9.719 ;20.517 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2226 ; 9.719 ;20.517 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2772 ;15.465 ;30.759 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2773 ;15.462 ;30.759 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2435 ; 8.465 ;20.890 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2436 ; 8.463 ;20.889 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3549 ;13.963 ;31.161 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3550 ;13.962 ;31.160 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 8K5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1300039527. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10792 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.750 REMARK 200 RESOLUTION RANGE LOW (A) : 85.751 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.19 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M K3 CITRATE, 20% PEG3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 85.75100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 49.50836 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.04067 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 85.75100 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 49.50836 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 32.04067 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 85.75100 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 49.50836 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.04067 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 99.01673 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 64.08133 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 99.01673 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 64.08133 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 99.01673 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 64.08133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LYS A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 26 REMARK 465 GLN A 27 REMARK 465 GLY A 28 REMARK 465 THR A 29 REMARK 465 PHE A 30 REMARK 465 GLY A 31 REMARK 465 TYR A 92 REMARK 465 ASN A 93 REMARK 465 ARG A 94 REMARK 465 CYS A 95 REMARK 465 ALA A 177 REMARK 465 LYS A 178 REMARK 465 ASN A 179 REMARK 465 LEU A 261 REMARK 465 TYR A 262 REMARK 465 GLU A 263 REMARK 465 LYS A 264 REMARK 465 LEU A 328 REMARK 465 SER A 329 REMARK 465 THR A 330 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 GLY B 3 REMARK 465 GLU B 4 REMARK 465 ARG B 5 REMARK 465 LYS B 6 REMARK 465 ASN B 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 6 -168.59 -123.01 REMARK 500 ASP A 7 -46.64 -139.16 REMARK 500 GLU A 9 104.64 -169.40 REMARK 500 CYS A 10 108.12 -164.39 REMARK 500 LYS A 40 -54.64 -120.71 REMARK 500 LEU A 51 160.95 79.68 REMARK 500 GLU A 57 72.57 -154.46 REMARK 500 SER A 98 -132.71 72.86 REMARK 500 GLU A 107 -74.51 -37.34 REMARK 500 LYS A 144 40.61 71.36 REMARK 500 ASP A 149 67.78 -158.94 REMARK 500 SER A 175 102.76 -176.30 REMARK 500 GLN A 181 -174.82 64.55 REMARK 500 ASN A 187 -73.94 -86.09 REMARK 500 VAL A 190 165.84 82.22 REMARK 500 PRO A 209 7.63 -57.60 REMARK 500 ASP A 257 40.25 -99.35 REMARK 500 GLU A 266 -124.67 62.73 REMARK 500 LYS A 274 67.94 -167.60 REMARK 500 ARG A 284 -39.95 83.21 REMARK 500 ASP A 313 43.11 -98.15 REMARK 500 TRP A 316 54.71 -115.49 REMARK 500 LYS A 325 48.80 -164.16 REMARK 500 LYS B 10 27.79 -141.39 REMARK 500 ASN B 21 62.23 -101.21 REMARK 500 ARG B 165 82.85 24.25 REMARK 500 ASP B 169 -78.96 -66.63 REMARK 500 THR B 186 43.41 -105.90 REMARK 500 REMARK 500 REMARK: NULL DBREF 8K5R A 1 330 UNP P50750 CDK9_HUMAN 1 330 DBREF 8K5R B 1 259 UNP O60563 CCNT1_HUMAN 1 259 SEQADV 8K5R ASP A 7 UNP P50750 SER 7 ENGINEERED MUTATION SEQADV 8K5R ASN A 8 UNP P50750 VAL 8 ENGINEERED MUTATION SEQADV 8K5R ARG A 44 UNP P50750 LYS 44 ENGINEERED MUTATION SEQADV 8K5R PHE A 138 UNP P50750 TYR 138 ENGINEERED MUTATION SEQADV 8K5R ALA A 280 UNP P50750 LYS 280 ENGINEERED MUTATION SEQADV 8K5R GLU A 307 UNP P50750 ASP 307 ENGINEERED MUTATION SEQADV 8K5R GLU A 311 UNP P50750 ASN 311 ENGINEERED MUTATION SEQADV 8K5R ALA B 26 UNP O60563 ARG 26 ENGINEERED MUTATION SEQADV 8K5R ARG B 77 UNP O60563 GLN 77 ENGINEERED MUTATION SEQADV 8K5R GLY B 96 UNP O60563 GLU 96 ENGINEERED MUTATION SEQADV 8K5R ARG B 106 UNP O60563 LYS 106 ENGINEERED MUTATION SEQADV 8K5R LEU B 241 UNP O60563 PHE 241 ENGINEERED MUTATION SEQRES 1 A 330 MET ALA LYS GLN TYR ASP ASP ASN GLU CYS PRO PHE CYS SEQRES 2 A 330 ASP GLU VAL SER LYS TYR GLU LYS LEU ALA LYS ILE GLY SEQRES 3 A 330 GLN GLY THR PHE GLY GLU VAL PHE LYS ALA ARG HIS ARG SEQRES 4 A 330 LYS THR GLY GLN ARG VAL ALA LEU LYS LYS VAL LEU MET SEQRES 5 A 330 GLU ASN GLU LYS GLU GLY PHE PRO ILE THR ALA LEU ARG SEQRES 6 A 330 GLU ILE LYS ILE LEU GLN LEU LEU LYS HIS GLU ASN VAL SEQRES 7 A 330 VAL ASN LEU ILE GLU ILE CYS ARG THR LYS ALA SER PRO SEQRES 8 A 330 TYR ASN ARG CYS LYS GLY SER ILE TYR LEU VAL PHE ASP SEQRES 9 A 330 PHE CYS GLU HIS ASP LEU ALA GLY LEU LEU SER ASN VAL SEQRES 10 A 330 LEU VAL LYS PHE THR LEU SER GLU ILE LYS ARG VAL MET SEQRES 11 A 330 GLN MET LEU LEU ASN GLY LEU PHE TYR ILE HIS ARG ASN SEQRES 12 A 330 LYS ILE LEU HIS ARG ASP MET LYS ALA ALA ASN VAL LEU SEQRES 13 A 330 ILE THR ARG ASP GLY VAL LEU LYS LEU ALA ASP PHE GLY SEQRES 14 A 330 LEU ALA ARG ALA PHE SER LEU ALA LYS ASN SER GLN PRO SEQRES 15 A 330 ASN ARG TYR TPO ASN ARG VAL VAL THR LEU TRP TYR ARG SEQRES 16 A 330 PRO PRO GLU LEU LEU LEU GLY GLU ARG ASP TYR GLY PRO SEQRES 17 A 330 PRO ILE ASP LEU TRP GLY ALA GLY CYS ILE MET ALA GLU SEQRES 18 A 330 MET TRP THR ARG SER PRO ILE MET GLN GLY ASN THR GLU SEQRES 19 A 330 GLN HIS GLN LEU ALA LEU ILE SER GLN LEU CYS GLY SER SEQRES 20 A 330 ILE THR PRO GLU VAL TRP PRO ASN VAL ASP ASN TYR GLU SEQRES 21 A 330 LEU TYR GLU LYS LEU GLU LEU VAL LYS GLY GLN LYS ARG SEQRES 22 A 330 LYS VAL LYS ASP ARG LEU ALA ALA TYR VAL ARG ASP PRO SEQRES 23 A 330 TYR ALA LEU ASP LEU ILE ASP LYS LEU LEU VAL LEU ASP SEQRES 24 A 330 PRO ALA GLN ARG ILE ASP SER GLU ASP ALA LEU GLU HIS SEQRES 25 A 330 ASP PHE PHE TRP SER ASP PRO MET PRO SER ASP LEU LYS SEQRES 26 A 330 GLY MET LEU SER THR SEQRES 1 B 259 MET GLU GLY GLU ARG LYS ASN ASN ASN LYS ARG TRP TYR SEQRES 2 B 259 PHE THR ARG GLU GLN LEU GLU ASN SER PRO SER ARG ALA SEQRES 3 B 259 PHE GLY VAL ASP PRO ASP LYS GLU LEU SER TYR ARG GLN SEQRES 4 B 259 GLN ALA ALA ASN LEU LEU GLN ASP MET GLY GLN ARG LEU SEQRES 5 B 259 ASN VAL SER GLN LEU THR ILE ASN THR ALA ILE VAL TYR SEQRES 6 B 259 MET HIS ARG PHE TYR MET ILE GLN SER PHE THR ARG PHE SEQRES 7 B 259 PRO GLY ASN SER VAL ALA PRO ALA ALA LEU PHE LEU ALA SEQRES 8 B 259 ALA LYS VAL GLU GLY GLN PRO LYS LYS LEU GLU HIS VAL SEQRES 9 B 259 ILE ARG VAL ALA HIS THR CYS LEU HIS PRO GLN GLU SER SEQRES 10 B 259 LEU PRO ASP THR ARG SER GLU ALA TYR LEU GLN GLN VAL SEQRES 11 B 259 GLN ASP LEU VAL ILE LEU GLU SER ILE ILE LEU GLN THR SEQRES 12 B 259 LEU GLY PHE GLU LEU THR ILE ASP HIS PRO HIS THR HIS SEQRES 13 B 259 VAL VAL LYS CYS THR GLN LEU VAL ARG ALA SER LYS ASP SEQRES 14 B 259 LEU ALA GLN THR SER TYR PHE MET ALA THR ASN SER LEU SEQRES 15 B 259 HIS LEU THR THR PHE SER LEU GLN TYR THR PRO PRO VAL SEQRES 16 B 259 VAL ALA CYS VAL CYS ILE HIS LEU ALA CYS LYS TRP SER SEQRES 17 B 259 ASN TRP GLU ILE PRO VAL SER THR ASP GLY LYS HIS TRP SEQRES 18 B 259 TRP GLU TYR VAL ASP ALA THR VAL THR LEU GLU LEU LEU SEQRES 19 B 259 ASP GLU LEU THR HIS GLU LEU LEU GLN ILE LEU GLU LYS SEQRES 20 B 259 THR PRO ASN ARG LEU LYS ARG ILE TRP ASN TRP ARG MODRES 8K5R TPO A 186 THR MODIFIED RESIDUE HET TPO A 186 11 HET VQE A 401 21 HETNAM TPO PHOSPHOTHREONINE HETNAM VQE (1S,3S)-N3-(5-PENTAN-3-YLPYRAZOLO[1,5-A]PYRIMIDIN-7- HETNAM 2 VQE YL)CYCLOPENTANE-1,3-DIAMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 VQE C16 H25 N5 HELIX 1 AA1 GLU A 15 SER A 17 5 3 HELIX 2 AA2 PRO A 60 LEU A 73 1 14 HELIX 3 AA3 LEU A 110 ASN A 116 1 7 HELIX 4 AA4 THR A 122 ASN A 143 1 22 HELIX 5 AA5 LYS A 151 ALA A 153 5 3 HELIX 6 AA6 PRO A 196 LEU A 201 1 6 HELIX 7 AA7 PRO A 208 ARG A 225 1 18 HELIX 8 AA8 THR A 233 GLY A 246 1 14 HELIX 9 AA9 VAL A 275 ARG A 284 1 10 HELIX 10 AB1 ASP A 285 LEU A 296 1 12 HELIX 11 AB2 ASP A 305 GLU A 311 1 7 HELIX 12 AB3 THR B 15 ASN B 21 1 7 HELIX 13 AB4 ASP B 30 ASN B 53 1 24 HELIX 14 AB5 SER B 55 TYR B 70 1 16 HELIX 15 AB6 PRO B 79 GLU B 95 1 17 HELIX 16 AB7 LYS B 100 HIS B 113 1 14 HELIX 17 AB8 SER B 123 GLY B 145 1 23 HELIX 18 AB9 HIS B 152 LEU B 163 1 12 HELIX 19 AC1 SER B 167 LEU B 184 1 18 HELIX 20 AC2 THR B 186 TYR B 191 1 6 HELIX 21 AC3 THR B 192 SER B 208 1 17 HELIX 22 AC4 HIS B 220 VAL B 225 5 6 HELIX 23 AC5 THR B 230 THR B 248 1 19 HELIX 24 AC6 ARG B 251 TRP B 256 5 6 SHEET 1 AA1 5 TYR A 19 LYS A 24 0 SHEET 2 AA1 5 VAL A 33 HIS A 38 -1 O LYS A 35 N ALA A 23 SHEET 3 AA1 5 ARG A 44 LYS A 49 -1 O LEU A 47 N PHE A 34 SHEET 4 AA1 5 ILE A 99 ASP A 104 -1 O PHE A 103 N ALA A 46 SHEET 5 AA1 5 LEU A 81 ARG A 86 -1 N CYS A 85 O TYR A 100 SHEET 1 AA2 3 HIS A 108 ASP A 109 0 SHEET 2 AA2 3 VAL A 155 ILE A 157 -1 O ILE A 157 N HIS A 108 SHEET 3 AA2 3 LEU A 163 LEU A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA3 2 ILE A 145 LEU A 146 0 SHEET 2 AA3 2 ARG A 172 ALA A 173 -1 O ARG A 172 N LEU A 146 LINK C TYR A 185 N TPO A 186 1555 1555 1.34 LINK C TPO A 186 N ASN A 187 1555 1555 1.34 CISPEP 1 ASP A 318 PRO A 319 0 -0.24 CRYST1 171.502 171.502 96.122 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005831 0.003366 0.000000 0.00000 SCALE2 0.000000 0.006733 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010403 0.00000